Carmine N. Stengone
CEO, President at Contineum Therapeutics, Inc. (CTNM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $401K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 2,50017,217 held (−13%) | $16.46 | $41K | -18.7% |
| Aug 3SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 2,50017,217 held (−13%) | $16.01 | $40K | -16.4% |
| Jul 8SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 2,50017,217 held (−13%) | $16.00 | $40K | -16.4% |
| Jul 1SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 10,00017,217 held (−37%) | $16.01 | $160K | -16.4% |
| Feb 26SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 4,40014,954 held (−23%) | $16.02 | $70K | -16.5% |
| Feb 26SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 2,70014,954 held (−15%) | $16.02 | $43K | -16.5% |
| Feb 13SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 40014,954 held (−3%) | $16.00 | $6K | -16.4% |
- Sell
CEO, President Carmine N. Stengone sold $41K of CTNM at $16.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Carmine N. Stengone sold $40K of CTNM at $16.01 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Carmine N. Stengone sold $40K of CTNM at $16.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Carmine N. Stengone sold $160K of CTNM at $16.01 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Carmine N. Stengone sold $70K of CTNM at $16.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Carmine N. Stengone sold $43K of CTNM at $16.02 — pre-scheduled 10b5-1 plan sale.